The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve mice

Behavioural Brain Research

Volumn 245, Issue , 2013, Pages 101-106

  Strekalova, Tatyana ^a,b   Anthony, Daniel C ^c   Dolgov, Oleg ^d,e   Anokhin, Konstantin ^e   Kubatiev, Aslan ^f   Steinbusch, Harry M W ^b   Schroeter, Careen ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^e P K ANOKHIN INSTITUTE OF NORMAL PHYSIOLOGY   (Russian Federation)

^f INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

Animal models of depression; Citalopram; Imipramine; Mouse; Pharmacological validation; Reference antidepressant

Indexed keywords

CITALOPRAM; IMIPRAMINE;

ANALYSIS OF VARIANCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; BODY WEIGHT; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; FLUID INTAKE; LEARNING DISORDER; LOCOMOTION; LONG TERM MEMORY; MENTAL PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; TREATMENT DURATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BODY WEIGHT; CITALOPRAM; DRINKING; DRUG DELIVERY SYSTEMS; EXPLORATORY BEHAVIOR; IMIPRAMINE; MALE; MEMORY; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; RECOGNITION (PSYCHOLOGY); SEROTONIN UPTAKE INHIBITORS; SUCROSE;

EID: 84875264483     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.02.015     Document Type: Article

References (24)

1. Munos B. Lessons from 60 years of pharmaceutical innovation. Nature Reviews Drug Discovery 2009, 8:959-968.
2. Pigott H.E., Leventhal A.M., Alter G.S., Boren J.J. Efficacy and effectiveness of antidepressants: current status of research. Psychotherapy and Psychosomatics 2010, 79:267-279.
3. Harro J. Animal models of depression vulnerability. Current Topics in Behavioral Neurosciences 2012, (August). [Epub ahead of print].
4. Borsini F. Models for depression in drug screening and preclinical studies: future directions. World Journal of Pharmacology 2012, 1:21-29.
5. Insel T.R., Sahakian B.J. Drug research: a plan for mental illness. Nature 2012, 483:269.
6. Schloss P., Betz H. Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1. Biochemistry 1995, 34:12590-12595.
7. Barker E.L., Kimmel H.L., Blakely R.D. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Molecular Pharmacology 1994, 46:799-807.
8. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews 2005, 29:571-625.
9. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
10. Overstreet D.H. Modeling depression in animal models. Methods in Molecular Biology 2012, 829:125-144.
11. Haduch A., Wojcikowski J., Daniel W.A. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A. European Neuropsychopharmacology 2006, 16:178-186.
12. Strekalova T., Gorenkova N., Schunk E., Dolgov O., Bartsch D. Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behavioural Pharmacology 2006, 3:271-287.
13. Malatynska E., Steinbusch H.M.W., Redkozubova O., Bolkunov A., Kubatiev A., Yeritsyan N.B., Vignisse J., Bachurin S., Strekalova T. Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression. Experimental Gerontology 2012, 47:552-564.
14. Couch Y., Anthony D.C., Dolgov O., Revischin A., Festoff B., Santos A.I. Set al. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain, Behavior, and Immunity 2013, 29:136-146.
15. Von Frijtag J.C., Van den Bos R., Spruijt B.M. Imipramine restores the long-term impairment of appetitive behavior in socially stressed rats. Psychopharmacology (Berl) 2002, 62:232-238.
16. Aschoff A. Circadian activity rhythms in hamsters and rats treated with imipramine in the drinking water. Chronobiology 1989, 16:9-20.
17. File S.E., Tucker J.C. Behavioral consequences of antidepressant treatment in rodents. Neuroscience and Biobehavioral Reviews 1986, 10:123-134.
18. Kugelberg F.C., Apelqvist G., Bengtsson F. Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in rats. Pharmacology & Toxicology 2002, 90:303-310.
19. Mogensen J., Pedersen T.K., Holm S. Effects of chronic imipramine on exploration, locomotion, and food/water intake in rats. Pharmacology Biochemistry and Behavior 1994, 47:427-435.
20. Holzer L., Paiva G., Halfon O. Quetiapine-induced weight gain and escitalopram. American Journal of Psychiatry 2005, 162:192-193.
21. Laboratory Mice and Rats. http://www.labome.com/method/Laboratory-Mice-and-Rats.html.
22. Strekalova T., Couch Y., Kholod N., Boyks M., Malin D., Leprince Steinbusch H.W. Update in the methodology of the chronic stress paradigm: internal control matters. Behavioral and Brain Functions 2011, 7:9.
23. Burbenskaya N.M., Nartsissov Y.R., Tsofina L.M., Komissarova I.A. The uncoupling effect of some psychotropic drugs on oxidative phosphorylation in rat liver mitochondria. Biochemistry and Molecular Biology International 1998, 45:261-268.
24. Daniel W.A., Haduch A., Syrek M., Boksa J. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment. European Neuropsychopharmacology 2006, 16:580-587.